Welcome to ULTRA!

Are you planning fibroid treatment with myomectomy or radiofrequency ablation (AcessaTM)? 

We want to hear from you! Join ULTRA to share your experience.

The ULTRA study enrollment ENDS July 1, 2022. If you are scheduled for AcessaTM on or before June 30, 2022 you are still eligible to enroll. Any procedures scheduled after this date are not eligible to enroll. 

You can enroll at these locations. Or, if you are having the Acessa procedure at any other location, and would like to enroll in ULTRA, please contact us


ULTRA is a nationwide study for women who would like to share their experience with radiofrequency ablation (AcessaTM) and myomectomy to treat uterine fibroids. This study is being done to help patients and doctors better understand how radiofrequency ablation (AcessaTMchanges fibroid symptoms, affects fertility and pregnancy, and impacts the need for additional fibroid treatment in the future.

Want to learn more about radiofrequency ablation (AcessaTM)? Click here.